ENTRY       D12623                      Drug
NAME        Nanrilkefusp alfa (USAN/INN)
SEQUENCE    ITCPPPMSVE HADIWVKSYS LYSRERYICN SGFKRKAGTS SLTECVLNKA TNVAHWTTPS
            LKCIRDPALV HQRPAPPSGG SGGGGSGGGS GGGGSGGNWV NVISDLKKIE DLIQSMHIDA
            TLYTESDVHP SCKVTAMKCF LLELQVISLE SGDASIHDTV ENLIILANNS LSSNGNVTES
            GCKECEELEE KNIKEFLQSF VHIVQMFINT S
            (Disulfide bridge: 3-45, 29-63, 132-182, 139-185)
  TYPE      Peptide
EFFICACY    Antineoplastic, Immunomodulator
TARGET      IL15RA (CD215) [HSA:3601] [KO:K05074]
  PATHWAY   hsa04060(3601)  Cytokine-cytokine receptor interaction
            hsa04630(3601)  JAK-STAT signaling pathway
            hsa04672(3601)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL15RA (CD215)
                 D12623  Nanrilkefusp alfa (USAN/INN)
DBLINKS     CAS: 1416390-27-6
///
